These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9143222)

  • 1. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke.
    Yenari MA; de Crespigny A; Palmer JT; Roberts S; Schrier SL; Albers GW; Moseley ME; Steinberg GK
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):401-11. PubMed ID: 9143222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke.
    Yenari MA; Lee LK; Beaulieu C; Sun GH; Kunis D; Chang D; Albers GW; Moseley ME; Steinberg GK
    J Stroke Cerebrovasc Dis; 1998; 7(3):179-86. PubMed ID: 17895078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging.
    Takano K; Carano RA; Tatlisumak T; Meiler M; Sotak CH; Kleinert HD; Fisher M
    Neurology; 1998 Apr; 50(4):870-5. PubMed ID: 9566365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging.
    Tong DC; Adami A; Moseley ME; Marks MP
    Arch Neurol; 2001 Apr; 58(4):587-93. PubMed ID: 11295989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y; Li Q; Yang T; Hussain M; Shuaib A
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    J Cereb Blood Flow Metab; 2001 Aug; 21(8):964-71. PubMed ID: 11487732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    J Cereb Blood Flow Metab; 1994 May; 14(3):472-7. PubMed ID: 8163589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI.
    Marks MP; Tong DC; Beaulieu C; Albers GW; de Crespigny A; Moseley ME
    Neurology; 1999 Jun; 52(9):1792-8. PubMed ID: 10371525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA.
    Jiang Q; Zhang ZG; Zhang L; Ding GL; Li L; Ewing JR; Lu M; Whitton P; Hu J; Li QJ; Zhang RL; Chopp M
    J Neurol Sci; 2004 Sep; 224(1-2):57-67. PubMed ID: 15450772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.
    del Zoppo GJ; Poeck K; Pessin MS; Wolpert SM; Furlan AJ; Ferbert A; Alberts MJ; Zivin JA; Wechsler L; Busse O
    Ann Neurol; 1992 Jul; 32(1):78-86. PubMed ID: 1642475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans.
    Fox I; Dawson A; Loynds P; Eisner J; Findlen K; Levin E; Hanson D; Mant T; Wagner J; Maraganore J
    Thromb Haemost; 1993 Feb; 69(2):157-63. PubMed ID: 8456428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
    Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S
    Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke.
    Bednar MM; McAuliffe T; Raymond S; Gross CE
    Stroke; 1990 Dec; 21(12):1705-9. PubMed ID: 2124736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.